Is Alzheimer’s Research Focusing on the Wrong Target?

The debate over whether Alzheimer’s research should focus on amyloid plaques is heating up. While antiamyloid drugs show promise in clearing these plaques and slightly slowing cognitive decline, their overall effectiveness remains uncertain. This raises questions about the direction of current Alzheimer’s research and whether the scientific community is on the right track. It’s crucial because if the primary focus is off, it could mean years or even decades of wasted effort and resources in the fight against Alzheimer’s, underscoring the need for a reevaluation of treatment strategies.